Boothbay Fund Management’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,368
Closed -$162K 2745
2022
Q3
$162K Hold
16,368
﹤0.01% 1921
2022
Q2
$161K Hold
16,368
﹤0.01% 1844
2022
Q1
$160K Hold
16,368
﹤0.01% 1966
2021
Q4
$159K Buy
16,368
+350
+2% +$199 ﹤0.01% 1569
2021
Q3
$156K Buy
16,018
+650
+4% +$412 ﹤0.01% 1655
2021
Q2
$148K Buy
+15,368
New +$8.7K ﹤0.01% 1647

Other funds holding EQHA.WS

Boothbay Fund Management's EQHA.WS Position: Q4 2022 in Review

Boothbay Fund Management sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 16,368 shares — an estimated $162K sold.

Boothbay Fund Management first reported a position in EQHA.WS in Q2 2021 and held it in 6 quarters. The position peaked at $162K in Q3 2022. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Boothbay Fund Management reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 16,368 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $162K.
  • Boothbay Fund Management first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
  • Boothbay Fund Management's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $162K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.